Depression News and Research

Latest Depression News and Research

Interactive multimedia computer program does not improve mental health in depressed patients

Among depressed patients evaluated in a primary care setting, use of an interactive multimedia computer program immediately prior to a primary care visit resulted in the increased receipt of antidepressant prescription recommendation, mental health referral, or both; however, it did not result in improvement in mental health at 12-week follow-up, according to a study in the November 6 issue of JAMA.

6 Nov 2013

Endocrine Society announces winners of organization's prestigious 2014 Laureate Awards

The Endocrine Society today announced it has selected 15 accomplished endocrinologists as winners of the organization's prestigious 2014 Laureate Awards.

5 Nov 2013

First-episode type predicts morbidity, disease course in bipolar disorder

Study findings suggest that the type of first episode in patients with bipolar disorder can predict the type and degree of future morbidity, as well as the disease course.

5 Nov 2013

Metacognitive training complements antipsychotic therapy

Metacognitive training may benefit patients with schizophrenia who only partially respond to antipsychotic treatment, study findings show.

5 Nov 2013

Comorbid anxiety problematic for adolescents with bipolar disorder

Anxiety disorders are common in children and adolescents with bipolar disorder and adversely affect their outcomes, suggest study findings.

5 Nov 2013

Health anxiety therapies: an interview with Professor Peter Tyrer, Imperial College, London

Health anxiety is a relatively new diagnosis and has not been adopted fully. The nearest approximation and formal classification systems is ‘illness anxiety’ as diagnosed in DSM-5, published in May 2013 (DSM-5, American Psychiatric Association, p.315).

5 Nov 2013

Reviva announces successful completion of End-of-Phase 2 meeting for RP5063 drug

Reviva Pharmaceuticals, Inc., a privately held pharmaceutical company focused on the discovery and development of new, safer and highly effective therapies for chronic indications, announced today the successful completion of an End-of-Phase 2 meeting with the Food and Drug Administration for its lead, new investigational antipsychotic drug, RP5063.

5 Nov 2013

Bisexual men, women face prejudice and discrimination from both heterosexual, homosexual people

Men who identify themselves as heterosexual are three times more likely to categorize bisexuality as "not a legitimate sexual orientation," an attitude that can encourage negative health outcomes in people who identify as bisexual, according to an analysis led by University of Pittsburgh Graduate School of Public Health researcher Mackey Friedman, Ph.D., M.P.H.

5 Nov 2013

LUHS offers support group for women with postpartum depression

Loyola University Health System (LUHS) will offer a support group for women with postpartum depression. The group meets from 9-10 a.m. on the second and fourth Wednesday of the month at Loyola Center for Health at Oakbrook Terrace located at 1S260 Summit Ave.

4 Nov 2013

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved a Prior Approval Supplement for EMBEDA (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII.

4 Nov 2013

Generic drug gabapentin appears to be safe, effective in treating alcohol dependence

The generic drug gabapentin, which is already widely prescribed for epilepsy and some kinds of pain, appears to be safe and effective in the treatment of alcohol dependence. The finding comes from a 150-patient randomized, placebo-controlled, double blind clinical trial conducted by scientists at The Scripps Research Institute.

4 Nov 2013

Researchers study quality, effectiveness and safety of generic drugs used to treat depression

Researchers at Washington University School of Medicine in St. Louis are studying the quality, effectiveness and safety of generic drugs used to treat depression.

4 Nov 2013

ACOEM urges employers to respond to the impact of diabetes on worker health and productivity

In recognition of November as National Diabetes Month, the American College of Occupational and Environmental Medicine (ACOEM) is urging employers to identify and respond to the impact of diabetes on worker health and productivity.

4 Nov 2013

Obesity is largest predictor of earlier onset puberty in girls, shows research

New research in Pediatrics shows obesity is the largest predictor of earlier onset puberty in girls, which is affecting white girls much sooner than previously reported.

4 Nov 2013

Self-harm warns of repeated suicide attempt risk in schizophrenia

Individuals who have attempted suicide and also have a history of self-harm should be thoroughly assessed for psychotic symptoms in order to prevent delayed treatment and the risk for repeated suicide attempts, say researchers.

31 Oct 2013

Alkermes reports 38% of year-over-year revenue growth from key products

Alkermes plc today reported financial results for the quarter ended Sept. 30, 2013. This is the second quarter of the nine-month period ending Dec. 31, 2013, as the company transitions to reporting on a calendar year basis.

31 Oct 2013

IQWiG completes first health economic evaluation

The German Institute for Quality and Efficiency in Health Care has completed its first health economic evaluation. The report on antidepressants published on 30 October 2013 shows that the "efficiency frontier method" works and can provide very helpful results.

31 Oct 2013

Left-handers more likely to suffer from psychotic disorders

Researchers have long studied the connections between hand dominance and different aspects of the human brain. A new study out today in SAGE Open finds that among those with mental illnesses, left-handers are more likely to suffer from psychotic disorders such as schizophrenia than mood disorders.

31 Oct 2013

e-Therapeutics begins ETS6103 phase IIb trial for major depressive disorder

e-Therapeutics plc announces that it has started a randomised double-blind controlled phase IIb trial of ETS6103 in major depressive disorder.

31 Oct 2013

Researchers highlight presence of specific antibodies that regulate appetite in obese patients

Obesity affects more than 15% of adults in France, and its constitutive mechanisms are still not completely explained. Normally, fine control of weight and food intake is coordinated by a specialised part of the brain (the hypothalamus).

31 Oct 2013

Depression News and Research

Latest Depression News and Research

Interactive multimedia computer program does not improve mental health in depressed patients

Endocrine Society announces winners of organization's prestigious 2014 Laureate Awards

First-episode type predicts morbidity, disease course in bipolar disorder

Metacognitive training complements antipsychotic therapy

Comorbid anxiety problematic for adolescents with bipolar disorder

Health anxiety therapies: an interview with Professor Peter Tyrer, Imperial College, London

Reviva announces successful completion of End-of-Phase 2 meeting for RP5063 drug

Bisexual men, women face prejudice and discrimination from both heterosexual, homosexual people

LUHS offers support group for women with postpartum depression

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Generic drug gabapentin appears to be safe, effective in treating alcohol dependence

Researchers study quality, effectiveness and safety of generic drugs used to treat depression

ACOEM urges employers to respond to the impact of diabetes on worker health and productivity

Obesity is largest predictor of earlier onset puberty in girls, shows research

Self-harm warns of repeated suicide attempt risk in schizophrenia

Alkermes reports 38% of year-over-year revenue growth from key products

IQWiG completes first health economic evaluation

Left-handers more likely to suffer from psychotic disorders

e-Therapeutics begins ETS6103 phase IIb trial for major depressive disorder

Researchers highlight presence of specific antibodies that regulate appetite in obese patients

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Depression News and Research

Latest Depression News and Research

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in